The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...
A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback